Cell senescence in human aging: A review of the theory

In Vivo

Volumn 14, Issue 1, 2000, Pages 29-34

  Fossel, Michael ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Aging; Aging disease; Cancer; Cell senescence; Degenerative disease; Telomerase; Telomeres

Indexed keywords

AGING; ALZHEIMER DISEASE; ATHEROSCLEROSIS; CANCER; CELL DIVISION; ENDOTHELIUM CELL; GENE EXPRESSION; GENETIC TRANSFECTION; GLIA; HUMAN; OSTEOARTHRITIS; PROGERIA; REVIEW; SENESCENCE; SKIN; TELOMERE;

EID: 0034026397     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (76)

1. Hayflick L, Moorhead PS: The limited in vitro lifetime of human diploid cell strains. Experimental Aging Research 25: 585-621, 1961.
2. Hayflick L: How and Why We Age. New York, Ballantine Books, 1994.
3. Banks DA, Fossel M: Telomeres, cancer, and aging, altering the human lifespan. JAMA 278: 1345-1348, 1997. Fossel M: Implications of Recent Work in Telomeres and Cell Senescence. Journal of Anti- Aging Medicine 1: 39-43, 1998.
4. Banks DA, Fossel M: Telomeres, cancer, and aging, altering the human lifespan. JAMA 278: 1345-1348, 1997. Fossel M: Implications of Recent Work in Telomeres and Cell Senescence. Journal of Anti-Aging Medicine 1: 39-43, 1998.
5. Blasco MA, DePinho RA, Greider CW, Hande MP, Lansdorp PM, Lee HW, Samper E: Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91: 25-34, 1997. Rudolph KL, Chang S, Lee HW, Blasco M, Gotlieb GJ, Greider C, DePinho RA: Longevity, Stress Response, and Cancer in Aging Telomerase- Deficient Mice. Cell 96: 701-712, 1999. Cristofalo VJ, Allen RG, Pignolo R J, Martin BG, Beck JC: Relationship between donor age and the replicative lifespan of human cells in culture: A reevaluation. Proc Natl Acad Sci USA 95: 10614-10619, 1998.
6. Blasco MA, DePinho RA, Greider CW, Hande MP, Lansdorp PM, Lee HW, Samper E: Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91: 25-34, 1997. Rudolph KL, Chang S, Lee HW, Blasco M, Gotlieb GJ, Greider C, DePinho RA: Longevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice. Cell 96: 701-712, 1999. Cristofalo VJ, Allen RG, Pignolo R J, Martin BG, Beck JC: Relationship between donor age and the replicative lifespan of human cells in culture: A reevaluation. Proc Natl Acad Sci USA 95: 10614-10619, 1998.
7. Blasco MA, DePinho RA, Greider CW, Hande MP, Lansdorp PM, Lee HW, Samper E: Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91: 25-34, 1997. Rudolph KL, Chang S, Lee HW, Blasco M, Gotlieb GJ, Greider C, DePinho RA: Longevity, Stress Response, and Cancer in Aging Telomerase- Deficient Mice. Cell 96: 701-712, 1999. Cristofalo VJ, Allen RG, Pignolo R J, Martin BG, Beck JC: Relationship between donor age and the replicative lifespan of human cells in culture: A reevaluation. Proc Natl Acad Sci USA 95: 10614-10619, 1998.
8. Fossel M: Reversing Human Aging New York, William Morrow and Company, 1996.
9. Lange, T: Telomeres and senescence: ending the debate. Science 279: 334-335, 1998. Bodnar AG, Chiu C, Frolkis M, Harley CB, Holt SE, Lichtsteiner S, Morin GB, Ouellette M, Shay JW, Wright WE: Extension of Life-Span by Introduction of Telomerase into Normal Human Cells. Science 279: 349-352, 1998. Benchimol S, Vaziri H: Reconstruction of telomerase activity in normal cells leads to elongation of telomeres and extended replicative life span. Current Biology 8: 279-282, 1998. Vaziri H: Extension of Life Span in Normal Human Cells by Telomerase Activation: A Revolution in Culhlral Senescence. Journal of Anti-Aging Medicine 1: 125-130, 1998.
10. Lange, T: Telomeres and senescence: ending the debate. Science 279: 334-335, 1998. Bodnar AG, Chiu C, Frolkis M, Harley CB, Holt SE, Lichtsteiner S, Morin GB, Ouellette M, Shay JW, Wright WE: Extension of Life-Span by Introduction of Telomerase into Normal Human Cells. Science 279: 349-352, 1998. Benchimol S, Vaziri H: Reconstruction of telomerase activity in normal cells leads to elongation of telomeres and extended replicative life span. Current Biology 8: 279-282, 1998. Vaziri H: Extension of Life Span in Normal Human Cells by Telomerase Activation: A Revolution in Culhlral Senescence. Journal of Anti-Aging Medicine 1: 125-130, 1998.
11. Lange, T: Telomeres and senescence: ending the debate. Science 279: 334-335, 1998. Bodnar AG, Chiu C, Frolkis M, Harley CB, Holt SE, Lichtsteiner S, Morin GB, Ouellette M, Shay JW, Wright WE: Extension of Life-Span by Introduction of Telomerase into Normal Human Cells. Science 279: 349-352, 1998. Benchimol S, Vaziri H: Reconstruction of telomerase activity in normal cells leads to elongation of telomeres and extended replicative life span. Current Biology 8: 279-282, 1998. Vaziri H: Extension of Life Span in Normal Human Cells by Telomerase Activation: A Revolution in Culhlral Senescence. Journal of Anti-Aging Medicine 1: 125-130, 1998.
12. Lange, T: Telomeres and senescence: ending the debate. Science 279: 334-335, 1998. Bodnar AG, Chiu C, Frolkis M, Harley CB, Holt SE, Lichtsteiner S, Morin GB, Ouellette M, Shay JW, Wright WE: Extension of Life-Span by Introduction of Telomerase into Normal Human Cells. Science 279: 349-352, 1998. Benchimol S, Vaziri H: Reconstruction of telomerase activity in normal cells leads to elongation of telomeres and extended replicative life span. Current Biology 8: 279-282, 1998. Vaziri H: Extension of Life Span in Normal Human Cells by Telomerase Activation: A Revolution in Culhlral Senescence. Journal of Anti-Aging Medicine 1: 125-130, 1998.
13. Funk W, et al: Experimental Cell Research: submitted for publication, 1999.
14. th Annual Meeting of the American Association for Cancer Research. March 28-April 1, 1998: New Orleans, La, 1998. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW: Correlating telomerase activity levels with human neuroblastnma outcomes. Nat Med 1: 249-55, 1995. Hiyama E, Hiyama K, Ohtsu K, Yamaoka H, Ichikawa T, Shay JW, Yokoyama T: Telomerase activity in neuroblastoma: is it a prognostic indicator of clinical behaviour? Eur J Cancer 33: 1932-1936, 1997. Shay JW, Gazdar AF: Telomeres in the early detection of cancer. J Clin Pathol 50: 106-109, 1997. Shay JW, Bacchetti S: A survey of telomerase in human cancer. Eur J Cancer 33: 787-791, 1997. Maitra A, Yashima K, Rathi A, Timmons CF, Rogers BB, Shay JW, Gazdar AF: The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors. Cancer 85: 741-749, 1999.
15. th Annual Meeting of the American Association for Cancer Research. March 28-April 1, 1998: New Orleans, La, 1998. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW: Correlating telomerase activity levels with human neuroblastnma outcomes. Nat Med 1: 249-55, 1995. Hiyama E, Hiyama K, Ohtsu K, Yamaoka H, Ichikawa T, Shay JW, Yokoyama T: Telomerase activity in neuroblastoma: is it a prognostic indicator of clinical behaviour? Eur J Cancer 33: 1932-1936, 1997. Shay JW, Gazdar AF: Telomeres in the early detection of cancer. J Clin Pathol 50: 106-109, 1997. Shay JW, Bacchetti S: A survey of telomerase in human cancer. Eur J Cancer 33: 787-791, 1997. Maitra A, Yashima K, Rathi A, Timmons CF, Rogers BB, Shay JW, Gazdar AF: The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors. Cancer 85: 741-749, 1999.
16. th Annual Meeting of the American Association for Cancer Research. March 28-April 1, 1998: New Orleans, La, 1998. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW: Correlating telomerase activity levels with human neuroblastnma outcomes. Nat Med 1: 249-55, 1995. Hiyama E, Hiyama K, Ohtsu K, Yamaoka H, Ichikawa T, Shay JW, Yokoyama T: Telomerase activity in neuroblastoma: is it a prognostic indicator of clinical behaviour? Eur J Cancer 33: 1932-1936, 1997. Shay JW, Gazdar AF: Telomeres in the early detection of cancer. J Clin Pathol 50: 106-109, 1997. Shay JW, Bacchetti S: A survey of telomerase in human cancer. Eur J Cancer 33: 787-791, 1997. Maitra A, Yashima K, Rathi A, Timmons CF, Rogers BB, Shay JW, Gazdar AF: The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors. Cancer 85: 741-749, 1999.
17. th Annual Meeting of the American Association for Cancer Research. March 28-April 1, 1998: New Orleans, La, 1998. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW: Correlating telomerase activity levels with human neuroblastnma outcomes. Nat Med 1: 249-55, 1995. Hiyama E, Hiyama K, Ohtsu K, Yamaoka H, Ichikawa T, Shay JW, Yokoyama T: Telomerase activity in neuroblastoma: is it a prognostic indicator of clinical behaviour? Eur J Cancer 33: 1932-1936, 1997. Shay JW, Gazdar AF: Telomeres in the early detection of cancer. J Clin Pathol 50: 106-109, 1997. Shay JW, Bacchetti S: A survey of telomerase in human cancer. Eur J Cancer 33: 787-791, 1997. Maitra A, Yashima K, Rathi A, Timmons CF, Rogers BB, Shay JW, Gazdar AF: The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors. Cancer 85: 741-749, 1999.
18. th Annual Meeting of the American Association for Cancer Research. March 28-April 1, 1998: New Orleans, La, 1998. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW: Correlating telomerase activity levels with human neuroblastnma outcomes. Nat Med 1: 249-55, 1995. Hiyama E, Hiyama K, Ohtsu K, Yamaoka H, Ichikawa T, Shay JW, Yokoyama T: Telomerase activity in neuroblastoma: is it a prognostic indicator of clinical behaviour? Eur J Cancer 33: 1932-1936, 1997. Shay JW, Gazdar AF: Telomeres in the early detection of cancer. J Clin Pathol 50: 106-109, 1997. Shay JW, Bacchetti S: A survey of telomerase in human cancer. Eur J Cancer 33: 787-791, 1997. Maitra A, Yashima K, Rathi A, Timmons CF, Rogers BB, Shay JW, Gazdar AF: The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors. Cancer 85: 741-749, 1999.
19. th Annual Meeting of the American Association for Cancer Research. March 28-April 1, 1998: New Orleans, La, 1998. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW: Correlating telomerase activity levels with human neuroblastnma outcomes. Nat Med 1: 249-55, 1995. Hiyama E, Hiyama K, Ohtsu K, Yamaoka H, Ichikawa T, Shay JW, Yokoyama T: Telomerase activity in neuroblastoma: is it a prognostic indicator of clinical behaviour? Eur J Cancer 33: 1932-1936, 1997. Shay JW, Gazdar AF: Telomeres in the early detection of cancer. J Clin Pathol 50: 106-109, 1997. Shay JW, Bacchetti S: A survey of telomerase in human cancer. Eur J Cancer 33: 787-791, 1997. Maitra A, Yashima K, Rathi A, Timmons CF, Rogers BB, Shay JW, Gazdar AF: The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors. Cancer 85: 741-749, 1999.
20. th Annual Meeting of the American Association for Cancer Research. March 28-April 1, 1998: New Orleans, La, 1998. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW: Correlating telomerase activity levels with human neuroblastnma outcomes. Nat Med 1: 249-55, 1995. Hiyama E, Hiyama K, Ohtsu K, Yamaoka H, Ichikawa T, Shay JW, Yokoyama T: Telomerase activity in neuroblastoma: is it a prognostic indicator of clinical behaviour? Eur J Cancer 33: 1932-1936, 1997. Shay JW, Gazdar AF: Telomeres in the early detection of cancer. J Clin Pathol 50: 106-109, 1997. Shay JW, Bacchetti S: A survey of telomerase in human cancer. Eur J Cancer 33: 787-791, 1997. Maitra A, Yashima K, Rathi A, Timmons CF, Rogers BB, Shay JW, Gazdar AF: The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors. Cancer 85: 741-749, 1999.
21. Wynn RF, Cross MA, Hatton C, et al: Accelerated telomere shortening in young recipients of allogenic bone-marrow transplants. Lancet 351: 178-181, 1998.
22. de Kruif P: Microbe Hunters. New York, Harcourt Brace & Company, 1954. Porter R: The Greatest Benefit to Mankind. New York, WW Norton Company, 1997.
23. de Kruif P: Microbe Hunters. New York, Harcourt Brace & Company, 1954. Porter R: The Greatest Benefit to Mankind. New York, WW Norton Company, 1997.
24. Banks & Fossel op cit Fossel M: Telomerase and the Aging Cell; Implicatioqls for Human Health. JAMA 279: 1732-1735, 1998.
25. Clark W: Means fo an End. New York, Oxford University Press, 1999.
26. Chang E, Harley CB: Telomere length as a measure of replicative histories in human vascular tissues. Proc Natl Acad Sci USA 92: 1190-1194, 1995. Cooper LT, Cooke JP, Dzau VJ: The vasculopathy of aging. J Gerontol 49: 191-196, 1994.
27. Chang E, Harley CB: Telomere length as a measure of replicative histories in human vascular tissues. Proc Natl Acad Sci USA 92: 1190- 1194, 1995. Cooper LT, Cooke JP, Dzau VJ: The vasculopathy of aging. J Gerontol 49: 191-196, 1994.
28. Bierman EL: Aging and Atherosclerosis. In Principles of Geriatric Medicine and Gerontology (Hazzard WR, Bierman EL, Blass JP, Ettinger WH Jr, Halter JB, eds) New York, McGraw Hill Third Edition, 1994, pp 509-516.
29. Fossel M. Cell Senescence in Human Aging New York, Oxford Press, in preparation.
30. Hayflick, 1994, op cit
31. Harley CB, Futcher AB, Greider CW: Telomeres shorten during aging of human fibroblasts. Nature 345: 458-460, 1990.
32. Dimri GP, Campisi J: Molecular and cell biology of replicative senescence. Cold Spring Harbor Symp Ouant Biol 54: 67-73, 1994. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano E, Linskens M, Rubelj I, Pereira-Smith O, Peacock M, Campisi J: A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92: 9363- 9367, 1995. Campisi J: The role of cellular senescence in skin aging. J Investig Dermatol Symp Proc 3: 1-5, 1998.
33. Dimri GP, Campisi J: Molecular and cell biology of replicative senescence. Cold Spring Harbor Symp Ouant Biol 54: 67-73, 1994. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano E, Linskens M, Rubelj I, Pereira-Smith O, Peacock M, Campisi J: A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92: 9363- 9367, 1995. Campisi J: The role of cellular senescence in skin aging. J Investig Dermatol Symp Proc 3: 1-5, 1998.
34. Dimri GP, Campisi J: Molecular and cell biology of replicative senescence. Cold Spring Harbor Symp Ouant Biol 54: 67-73, 1994. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano E, Linskens M, Rubelj I, Pereira-Smith O, Peacock M, Campisi J: A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92: 9363- 9367, 1995. Campisi J: The role of cellular senescence in skin aging. J Investig Dermatol Symp Proc 3: 1-5, 1998.
35. Fossel in preparation, op cit.
36. Chang & Harley, 1995, op cit.
37. Kumazaki T: Modulation of gene expression during aging of human vascular endothelial cells. Hiroshima J Med Sci 42: 97, 1993.
38. Cooper et al 1994, op cit.
39. Fossel 1996, op cit. Brown WT, Zebrower M, Kieras FJ: Progeria: a genetic disease model of premature aging. In Genetic Effects on Aging II(Harrison DE, ed). Caldwell, NJ, Telford Press, 1990, Chapter 29.
40. Fossel 1996, op cit. Brown WT, Zebrower M, Kieras FJ: Progeria: a genetic disease model of premature aging. In Genetic Effects on Aging II(Harrison DE, ed). Caldwell, NJ, Telford Press, 1990, Chapter 29.
41. Allsopp RC et al: Telomere length predicts replicative capacity of human fibroblasts. Proc Nat Acad Sci USA: 89: 10114-10118, 1992.
42. Brown, 1990, op cit.
43. Bodnar et al, 1998, op cit Vaziri 1998, op cit Benchimol & Vaziri 1998, op cit.
44. Bodnar et al, 1998, op cit Vaziri 1998, op cit Benchimol & Vaziri 1998, op cit.
45. Fossel 1996, op cit Fossel 1998, op cit.
46. Fossel 1996, op cit Fossel 1998, op cit.
47. Campisi 1998, op cit.
48. Effros RB, Valenzuela HF: Immunosenescence: analysis and genetic modulation of replicative senescence in T cells. Journal of Anti-Aging Medicine 1: 305-313, 1998.
49. Fossel 1998, op cit.
50. Fossel 1996, op cit.
51. Mayeux R, Schofield PW: Alzheimer's Disease. In Principles of Geriatric Medicine and Gerontology (Hazzard WR, Bierman EL, Blass JP, Ettinger WH Jr, Halter JB, eds) New York, McGraw Hill Third Edition, 1994, chapter 92.
52. Vaziri H, et al: Loss of telomeric DNA during aging of normal and trisomy 21 human leukocytes". American Journal of Human Genetics, 52: 661, 1993.
53. Fossel 1998, op cit.
54. Chiu C-P, Dragowska W, Kim NW, Vaziri H, Yui J, Thomas TE, et al: Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells 14: 239-248, 1996. Shay J: Accelerated telomere shortening in bone marrow recipients. Lancet 351: 153-154, 1998. Moore MA: Stem cell proliferation: ex vivo and in vivo observations. Stem Cells 15: 239-248, 1997. Wynn, 1998, op cit .
55. Chiu C-P, Dragowska W, Kim NW, Vaziri H, Yui J, Thomas TE, et al: Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells 14: 239-248, 1996. Shay J: Accelerated telomere shortening in bone marrow recipients. Lancet 351: 153-154, 1998. Moore MA: Stem cell proliferation: ex vivo and in vivo observations. Stem Cells 15: 239-248, 1997. Wynn, 1998, op cit .
56. Chiu C-P, Dragowska W, Kim NW, Vaziri H, Yui J, Thomas TE, et al: Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells 14: 239-248, 1996. Shay J: Accelerated telomere shortening in bone marrow recipients. Lancet 351: 153-154, 1998. Moore MA: Stem cell proliferation: ex vivo and in vivo observations. Stem Cells 15: 239-248, 1997. Wynn, 1998, op cit .
57. Chiu C-P, Dragowska W, Kim NW, Vaziri H, Yui J, Thomas TE, et al: Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow. Stem Cells 14: 239-248, 1996. Shay J: Accelerated telomere shortening in bone marrow recipients. Lancet 351: 153-154, 1998. Moore MA: Stem cell proliferation: ex vivo and in vivo observations. Stem Cells 15: 239-248, 1997. Wynn, 1998, op cit .
58. Effros, 1998, op cit.
59. Shelton DS, Chang E, Whittier PS, Choi D and Funk WD: Microarray analysis of replicative senescence. Current Biology, submitted for publication, 1999.
60. Funk, 1999, op cit.
61. Friedmann T: The Development of Human Gene Therapy. Cold Spring Harbor N.Y., Cold Spring Harbor Laboratory Press, 1999.
62. Jacks T, Weinberg RA: Cell-cycle control and its watchman. Nature 381: 643-644, 1996. Sherr CJ: Cancer Cell Cycles. Science 274: 1672- 1677, 1996.
63. Jacks T, Weinberg RA: Cell-cycle control and its watchman. Nature 381: 643-644, 1996. Sherr CJ: Cancer Cell Cycles. Science 274: 1672-1677, 1996.
64. Shay & Gazdar, 1997, op cit. DePinho RA, de Lange T: Unlimited Mileage from Telomerase? Science 283: 947-950, 1999.
65. Shay & Gazdar, 1997, op cit. DePinho RA, de Lange T: Unlimited Mileage from Telomerase? Science 283: 947-950, 1999.
66. Counter CM, Hirte HW, Bacchetti S, Harley CB: Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 91: 2900-2904, 1994. Fossel 1996, op cit Banks & Fossel 1997, op cit.
67. Counter CM, Hirte HW, Bacchetti S, Harley CB: Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 91: 2900-2904, 1994. Fossel 1996, op cit Banks & Fossel 1997, op cit.
68. Counter CM, Hirte HW, Bacchetti S, Harley CB: Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci USA 91: 2900-2904, 1994. Fossel 1996, op cit Banks & Fossel 1997, op cit.
69. Avilion AA: Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Research 56: 645-650, 1996. Fossel 1998, op cit Ramirez RD, Wright WE, Shay JW, Taylor RS: Telomerase activity concentrates in the mitotically active segments of human hair follicles. J Invest Dermatol 108: 113-117, 1997. Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JJ: Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 18: 173-179, 1998. Englehardt M, et al: Telomerase regulation, cell cycle, and telomere stability in primitive hematopoetic cells. Blood 90: 182, 1997. Chiu, 1996, op cit.
70. Avilion AA: Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Research 56: 645-650, 1996. Fossel 1998, op cit Ramirez RD, Wright WE, Shay JW, Taylor RS: Telomerase activity concentrates in the mitotically active segments of human hair follicles. J Invest Dermatol 108: 113-117, 1997. Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JJ: Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 18: 173-179, 1998. Englehardt M, et al: Telomerase regulation, cell cycle, and telomere stability in primitive hematopoetic cells. Blood 90: 182, 1997. Chiu, 1996, op cit.
71. Avilion AA: Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Research 56: 645-650, 1996. Fossel 1998, op cit Ramirez RD, Wright WE, Shay JW, Taylor RS: Telomerase activity concentrates in the mitotically active segments of human hair follicles. J Invest Dermatol 108: 113-117, 1997. Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JJ: Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 18: 173-179, 1998. Englehardt M, et al: Telomerase regulation, cell cycle, and telomere stability in primitive hematopoetic cells. Blood 90: 182, 1997. Chiu, 1996, op cit.
72. Avilion AA: Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Research 56: 645-650, 1996. Fossel 1998, op cit Ramirez RD, Wright WE, Shay JW, Taylor RS: Telomerase activity concentrates in the mitotically active segments of human hair follicles. J Invest Dermatol 108: 113-117, 1997. Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JJ: Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 18: 173-179, 1998. Englehardt M, et al: Telomerase regulation, cell cycle, and telomere stability in primitive hematopoetic cells. Blood 90: 182, 1997. Chiu, 1996, op cit.
73. Avilion AA: Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Research 56: 645-650, 1996. Fossel 1998, op cit Ramirez RD, Wright WE, Shay JW, Taylor RS: Telomerase activity concentrates in the mitotically active segments of human hair follicles. J Invest Dermatol 108: 113-117, 1997. Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JJ: Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 18: 173-179, 1998. Englehardt M, et al: Telomerase regulation, cell cycle, and telomere stability in primitive hematopoetic cells. Blood 90: 182, 1997. Chiu, 1996, op cit.
74. Avilion AA: Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Research 56: 645-650, 1996. Fossel 1998, op cit Ramirez RD, Wright WE, Shay JW, Taylor RS: Telomerase activity concentrates in the mitotically active segments of human hair follicles. J Invest Dermatol 108: 113-117, 1997. Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JJ: Telomerase activity in human germline and embryonic tissues and cells. Dev Genet 18: 173-179, 1998. Englehardt M, et al: Telomerase regulation, cell cycle, and telomere stability in primitive hematopoetic cells. Blood 90: 182, 1997. Chiu, 1996, op cit.
75. Shay & Bacchetti, 1997, op cit.
76. Jiang X, Jimenez G, Chang E, Frolkis M, Kusler B, Sage M, Beeche M, Bodnar AG, Wahl GM, Tlsty TD, Chiu C Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nature Genetics 21: 111-114, 1999.